Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP1 | P22413 | 2/20 | 0.52 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.50 |
| ▸ | P2RY2 | P41231 | 5/20 | 0.49 |
| ▸ | P2RX1 | P51575 | 3/20 | 0.49 |
| ▸ | P2RX3 | P56373 | 3/20 | 0.49 |
| ▸ | P2RX2 | Q9UBL9 | 2/20 | 0.49 |
| ▸ | P2RY1 | P47900 | 5/20 | 0.48 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.48 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.46 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.46 |
| ▸ | P2RX4 | Q99571 | 2/20 | 0.46 |
| ▸ | SRC | P12931 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1035726 | 0.99 | ENPP1 (0.51) | ENPP1ENPP3P2RY2P2RX1P2RX3 | |
| SCHEMBL8509835 | 0.97 | ENPP1 (0.50) | ENPP1ENPP3P2RY2P2RX1P2RX3 | |
| SCHEMBL27721221 | 0.88 | FGFR1 (0.47) | ENPP1ENPP3P2RY2P2RX1P2RX3 | |
| SCHEMBL283730 | 0.87 | FGFR1 (0.51) | ENPP1ENPP3P2RY2P2RY1P2RY11 | |
| SCHEMBL1074484 | 0.83 | CDK1 (0.40) | ENPP1ENPP3P2RY2P2RX1P2RX3 | |
| Acetone SCHEMBL28162073 | 0.82 | CYP3A4 (0.47) | ENPP1P2RY2P2RY1P2RY11FGFR1 | |
| Niacinamide SCHEMBL27733580 | 0.82 | EGFR (0.52) | ENPP1ENPP3P2RY2P2RX1P2RX3 | |
| SCHEMBL27903676 | 0.82 | CYP3A4 (0.47) | ENPP1ENPP3P2RY2P2RX1P2RX3 | |
| SCHEMBL5089696 | 0.81 | ENPP1 (0.46) | ENPP1ENPP3P2RY2P2RX1P2RX3 | |
| SCHEMBL28139965 | 0.80 | FGFR1 (0.43) | ENPP1ENPP3P2RY2P2RX1P2RX3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 506 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4596713-A1 | DNA WITH ENHANCED RESISTANCE AGAINST EXONUCLEASES AND METHODS FOR THE PRODUCTION THEREOF | 4basebio UK Ltd (GB) | 2025-08-06 | — | — | EP | claimed |
| CN-119614709-A | Detection method and application of whole genome 5-hydroxymethylcytosine | 青岛科技大学 | 2025-03-14 | — | — | CN | claimed |
| WO-2024250923-A1 | CHEMICALLY MODIFIED NUCLEOSIDE, CHEMICALLY MODIFIED NUCLEOSIDE TRIPHOSPHATE AND USE THEREOF | 中国科学院深圳先进技术研究院 | 2024-12-12 | — | — | WO | claimed |
| US-20240350027-A1 | Methods and Apparatus for Benchtop Metabolite Profiling in Situ | VIBO HEALTH INC (US) | 2024-10-24 | — | — | US | claimed |
| EP-4436358-A1 | PROCESSES AND SYSTEMS FOR INCREASING DRY MATTER IN HYDROPONICALLY GROWN CELLULOSIC MATERIALS | Hydrogreen, Inc. (CA) | 2024-10-02 | — | — | EP | claimed |
| WO-2023096635-A1 | PROCESSES AND SYSTEMS FOR INCREASING DRY MATTER IN HYDROPONICALLY GROWN CELLULOSIC MATERIALS | HYDROGREEN, INC (CA) | 2023-06-01 | — | — | WO | claimed |
| US-20230157229-A1 | PROCESSES AND SYSTEMS FOR INCREASING DRY MATTER IN HYDROPONICALLY GROWN CELLULOSIC MATERIALS | Hydrogreen, Inc. (CA) | 2023-05-25 | — | — | US | claimed |
| CN-111505284-B | Test paper strip and sensor for detecting novel coronavirus SARS-CoV-2, and preparation and application thereof | 中国科学院重庆绿色智能技术研究院 | 2023-05-02 | — | — | CN | claimed |
| WO-2023022997-A1 | METHODS AND APPARATUS FOR BENCHTOP METABOLITE PROFILING IN SITU | ViBo Health Inc. (US) | 2023-02-23 | — | — | WO | claimed |
| US-20220275028-A1 | Systems, Methods And Compositions For Recombinant In Vitro Transcription And Translation Utilizing Thermophilic Proteins | NATURE'S TOOLBOX, INC. | 2022-09-01 | — | — | US | claimed |
| US-7022494-B2 | Detection of potassium ions using ion-sensitive enzymes | GENERAL ATOMICS (US) | 2006-04-04 | — | — | US | claimed |
| US-20050266508-A1 | Detection of potassium ions using ion-sensitive enzymes | DIAZYME LABORATORIES, INC. | 2005-12-01 | — | — | US | claimed |
| WO-2005029038-A2 | DETECTION OF POTASSIUM IONS USING ION-SENSITIVE ENZYMES | GENERAL ATOMICS (US) | 2005-03-31 | — | — | WO | claimed |
| US-20050069970-A1 | Detection of potassium ions using ion-sensitive enzymes | GENERAL ATOMICS | 2005-03-31 | — | — | US | claimed |
| US-20030212006-A1 | Method for reducing free radical formation in healthy individuals undergoing hypoxic exercise and medical conditions with increased oxygen free radicals | BIONERGY, INC. | 2003-11-13 | — | — | US | claimed |
| EP-1032700-A1 | SEPARATION OF NUCLEIC ACIDS BY ANTIBODIES TO HALOGENATED NUCLEOTIDES | New York Medical College (US) | 2000-09-06 | — | — | EP | claimed |
| CN-1049246-C | Method for preparing powder type culture-medium of animal cell | KANGDA AMINO ACID FASTORY SHAN (CN) | 2000-02-09 | — | — | CN | claimed |
| WO-1999006592-A9 | SEPARATION OF NUCLEIC ACIDS BY ANTIBODIES TO HALOGENATED NUCLEOTIDES | NEW YORK MEDICAL COLLEGE (US) | 1999-05-06 | — | — | WO | claimed |
| WO-1999006592-A1 | SEPARATION OF NUCLEIC ACIDS BY ANTIBODIES TO HALOGENATED NUCLEOTIDES | NEW YORK MEDICAL COLLEGE (US) | 1999-02-11 | — | — | WO | claimed |
| EP-0147713-A2 | Enzymatic ATP and FMN assay | Miles Italiana SpA (IT) | 1985-07-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220275028-A1 | Systems, Methods And Compositions For Recombinant In Vitro Transcription And Translation Utilizing Thermophilic Proteins | MRPL21, RNGTT, MRPS23 | ENPP1 2948/4885ENPP3 2055/4885P2RY2 4688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.